NCT02003638View on ClinicalTrials.gov

Assessment Of Vascular Health After Niacin Therapy (AVANT)

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Coronary Artery DiseaseCarotid Artery DiseasePeripheral Artery Disease
Interventions
DRUG

Niacin

Niacin titrated to 6000 mg daily

DRUG

Placebo

Placebo provided in the same pill quantity as niacin arm

Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT02003638 - Assessment Of Vascular Health After Niacin Therapy (AVANT) | Biotech Hunter | Biotech Hunter